C. Christiansen, M. Christensen, C. Hagen
Jan 1, 1981
Citations
0
Influential Citations
34
Citations
Quality indicators
Journal
Acta Obstetricia et Gynecologica Scandinavica
Abstract
Abstract. A 2‐year double‐blind trial designed for studying the separate and combined effects of bendroflumethiazide (BFTZ) and cyclical administration of 17β‐estradiol + estriol/norethisterone (E/N) on coronary risk factors and bone mineral loss (reported elsewhere) was undertaken. Serum lipids, fasting blood glucose, body weight and blood pressure were measured every 3 months in 97 normal women in their early menopause. All participants received a supplement of 500 mg calcium and were randomized to one of the following treatment groups: 1) placebo (P) + P (n = 33); 2) P + E/N (n = 21); 3) BFTZ + E/N (n = 22); and 4) BFTZ + P (n = 21).